Form 4 Filing for Alpha Tau Medical Ltd.

Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported transactions on July 2, 2026, involving the acquisition of 17,873 ordinary shares at $2.98 per share and the disposal of 17,873 ordinary shares at $13.0027 per share. Following these transactions, the post-transaction share count for directly owned ordinary shares is 108,053.